Latest filing published 13 May 2019 for Trevi Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -68.4%Entry US$8.90 · Close at T+365 US$2.81
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mellon Family Investment Co V: trading record in brief
Mellon Family Investment Co V discloses dealings in Trevi Therapeutics, Inc. to SEC (Form 4). We count 3 filings, every one of them for a trade on 9 May 2019.
Every open-market trade on record is a purchase: 1 purchase worth €891k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 13 May 2019: a transaction, in Trevi Therapeutics, Inc. The last purchase on record was published on 13 May 2019, which is 2,737 days ago. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mellon Family Investment Co V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 222,816 sharesCommon StockSEC:0000899243-19-013260:0
- 24,340 shares0Common StockSEC:0000899243-19-013260:1
- 100,000 shares@ US$10.00100.0% of flowCommon StockSEC:0000899243-19-013260:2Canonical exit: 7 Aug 2019 (T+90)
3 of 3 declarations
